MEREO BIOPHARMA GROUP PLC Identifiable Intangible Assets Recognised As Of Acquisition Date
MEREO BIOPHARMA GROUP PLC (MREO) had Identifiable Intangible Assets Recognised As Of Acquisition Date of GBP 12.69 million as of 2019-04-23, per its 20-F filed 2020-06-15.
Discontinued › Notes › Intangible Assets
ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate · last filed 2020-06-15
- 2019-04-23: Identifiable Intangible Assets Recognised As Of Acquisition Date 12.69M GBP.
| Period end | Identifiable Intangible Assets Recognised As Of Acquisition Date |
|---|---|
| 2019-04-23 | 12.69M GBP 20-F · filed 2020-06-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |